AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-81
Results: 1-25/81
CELL-SURFACE DENSITY OF P185(C-ERBB-2) DETERMINES SUSCEPTIBILITY TO ANTI-P185(C-ERBB-2)-RICIN-A CHAIN (RTA) IMMUNOTOXIN THERAPY ALONE AND IN COMBINATION WITH ANTI-P170(EGFR)-RTA IN OVARIAN-CANCER CELLS
Authors: DEAN GS PUSZTAI L XU FJ OBRIANT K DESOMBRE K CONAWAY M BOYER CM MENDELSOHN J BAST RC
Citation: Gs. Dean et al., CELL-SURFACE DENSITY OF P185(C-ERBB-2) DETERMINES SUSCEPTIBILITY TO ANTI-P185(C-ERBB-2)-RICIN-A CHAIN (RTA) IMMUNOTOXIN THERAPY ALONE AND IN COMBINATION WITH ANTI-P170(EGFR)-RTA IN OVARIAN-CANCER CELLS, Clinical cancer research, 4(10), 1998, pp. 2545-2550
EXPRESSION OF P16 INDUCES TRANSCRIPTIONAL DOWN-REGULATION OF THE RB GENE
Authors: FANG XJ JIN XM XU HJ LIU L PENG HQ HOGG D ROTH JA YU YH XU FJ BAST RC MILLS GB
Citation: Xj. Fang et al., EXPRESSION OF P16 INDUCES TRANSCRIPTIONAL DOWN-REGULATION OF THE RB GENE, Oncogene, 16(1), 1998, pp. 1-8
1997 UPDATE OF RECOMMENDATIONS FOR THE USE OF TUMOR-MARKERS IN BREASTAND COLORECTAL-CANCER
Authors: BAST RC DESCH CE HAYES DF KEMENY NE RAVDIN P SOMERFIELD MR SMITH TJ
Citation: Rc. Bast et al., 1997 UPDATE OF RECOMMENDATIONS FOR THE USE OF TUMOR-MARKERS IN BREASTAND COLORECTAL-CANCER, Journal of clinical oncology, 16(2), 1998, pp. 793-795
COEXPRESSION OF THE HER-2 GENE-PRODUCT, P185(HER-2), AND EPIDERMAL GROWTH-FACTOR RECEPTOR, P170(EGF-R), ON EPITHELIAL OVARIAN CANCERS AND NORMAL-TISSUES
Authors: BAST RC PUSZTAI L KERNS BJ MACDONALD JA JORDAN P DALY L BOYER CM MENDELSOHN J BERCHUCK A
Citation: Rc. Bast et al., COEXPRESSION OF THE HER-2 GENE-PRODUCT, P185(HER-2), AND EPIDERMAL GROWTH-FACTOR RECEPTOR, P170(EGF-R), ON EPITHELIAL OVARIAN CANCERS AND NORMAL-TISSUES, Hybridoma, 17(4), 1998, pp. 313-321
A PHASE-I STUDY OF A DAILY X3 SCHEDULE OF INTRAVENOUS VINORELBINE FORREFRACTORY EPITHELIAL OVARIAN-CANCER
Authors: GERSHENSON DM BURKE TW MORRIS M BAST RC GUASPARI A HOHNEKER J WHARTON JT
Citation: Dm. Gershenson et al., A PHASE-I STUDY OF A DAILY X3 SCHEDULE OF INTRAVENOUS VINORELBINE FORREFRACTORY EPITHELIAL OVARIAN-CANCER, Gynecologic oncology (Print), 70(3), 1998, pp. 404-409
SUPPRESSION OF DIACYLGLYCEROL LEVELS BY ANTIBODIES REACTIVE WITH THE C-ERBB-2 (HER-2 NEU) GENE-PRODUCT P185(C-ERBB-2) IN BREAST AND OVARIAN-CANCER CELL-LINES/
Authors: BOENTE MP BERCHUCK A WHITAKER RS KALEN A XU FJ CLARKEPEARSON DL BELL RM BAST RC
Citation: Mp. Boente et al., SUPPRESSION OF DIACYLGLYCEROL LEVELS BY ANTIBODIES REACTIVE WITH THE C-ERBB-2 (HER-2 NEU) GENE-PRODUCT P185(C-ERBB-2) IN BREAST AND OVARIAN-CANCER CELL-LINES/, Gynecologic oncology (Print), 70(1), 1998, pp. 49-55
CA-125 IN OVARIAN-CANCER - ADVANCES AND CONTROVERSY
Authors: FRITSCHE HA BAST RC
Citation: Ha. Fritsche et Rc. Bast, CA-125 IN OVARIAN-CANCER - ADVANCES AND CONTROVERSY, Clinical chemistry, 44(7), 1998, pp. 1379-1380
ACTIVATION OF THE RAS-MITOGEN-ACTIVATED PROTEIN-KINASE PATHWAY AND PHOSPHORYLATION OF ETS-2 AT POSITION THREONINE-72 IN HUMAN OVARIAN-CANCER CELL-LINES
Authors: PATTON SE MARTIN ML NELSEN LL FANG XJ MILLS GB BAST RC OSTROWSKI MC
Citation: Se. Patton et al., ACTIVATION OF THE RAS-MITOGEN-ACTIVATED PROTEIN-KINASE PATHWAY AND PHOSPHORYLATION OF ETS-2 AT POSITION THREONINE-72 IN HUMAN OVARIAN-CANCER CELL-LINES, Cancer research, 58(10), 1998, pp. 2253-2259
HEREGULIN AND AGONISTIC ANTI-P185(C-ERBB2) ANTIBODIES INHIBIT PROLIFERATION BUT INCREASE INVASIVENESS OF BREAST-CANCER CELLS THAT OVEREXPRESS P185(C-ERBB2) - INCREASED INVASIVENESS MAY CONTRIBUTE TO POOR-PROGNOSIS
Authors: XU FJ STACK S BOYER C OBRIANT K WHITAKER R MILLS GB YU YH BAST RC
Citation: Fj. Xu et al., HEREGULIN AND AGONISTIC ANTI-P185(C-ERBB2) ANTIBODIES INHIBIT PROLIFERATION BUT INCREASE INVASIVENESS OF BREAST-CANCER CELLS THAT OVEREXPRESS P185(C-ERBB2) - INCREASED INVASIVENESS MAY CONTRIBUTE TO POOR-PROGNOSIS, Clinical cancer research, 3(9), 1997, pp. 1629-1634
SUMMARY OF THE FIRST FREIREICH,EMIL,J SYMPOSIUM
Authors: BAST RC
Citation: Rc. Bast, SUMMARY OF THE FIRST FREIREICH,EMIL,J SYMPOSIUM, Clinical cancer research, 3(12), 1997, pp. 2708-2710
CONCLUSIONS AND RECOMMENDATIONS FROM THE HELENE-HARRIS-MEMORIAL-TRUST6TH BIENNIAL INTERNATIONAL FORUM ON OVARIAN-CANCER, MAY 10-14, 1997, LOS-ANGELES, CALIFORNIA, USA
Authors: SHARP F BLACKETT AD BEREK JS BAST RC
Citation: F. Sharp et al., CONCLUSIONS AND RECOMMENDATIONS FROM THE HELENE-HARRIS-MEMORIAL-TRUST6TH BIENNIAL INTERNATIONAL FORUM ON OVARIAN-CANCER, MAY 10-14, 1997, LOS-ANGELES, CALIFORNIA, USA, International journal of gynecological cancer, 7(5), 1997, pp. 416-424
RADIOIODINATED ANTIBODY TARGETING OF THE HER-2 NEU ONCOPROTEIN/
Authors: XU FJ YU YH BAE DS ZHAO XG SLADE SK BOYER CM BAST RC ZALUTSKY MR
Citation: Fj. Xu et al., RADIOIODINATED ANTIBODY TARGETING OF THE HER-2 NEU ONCOPROTEIN/, Nuclear medicine and biology, 24(5), 1997, pp. 451-459
REEXPRESSION OF THE RETINOBLASTOMA PROTEIN IN TUMOR-CELLS INDUCES SENESCENCE AND TELOMERASE INHIBITION
Authors: XU HJ ZHOU YL JI W PERNG GS KRUZELOCK R KONG CT BAST RC MILLS GB LI J HU SX
Citation: Hj. Xu et al., REEXPRESSION OF THE RETINOBLASTOMA PROTEIN IN TUMOR-CELLS INDUCES SENESCENCE AND TELOMERASE INHIBITION, Oncogene, 15(21), 1997, pp. 2589-2596
TUMOR-MARKER GUIDELINES - REPLY
Authors: BAST RC
Citation: Rc. Bast, TUMOR-MARKER GUIDELINES - REPLY, Journal of clinical oncology, 15(5), 1997, pp. 2175-2176
GUIDELINES FOR THE USE OF CARCINOEMBRYONIC ANTIGEN IN COLORECTAL-CANCER - REPLY
Authors: BAST RC
Citation: Rc. Bast, GUIDELINES FOR THE USE OF CARCINOEMBRYONIC ANTIGEN IN COLORECTAL-CANCER - REPLY, Journal of clinical oncology, 15(2), 1997, pp. 864-864
IS OVX1 A SUITABLE MARKER FOR ENDOMETRIAL CANCER
Authors: BECK EP WAGNER M ANSELMINO L XU FJ BAST RC JAEGER W
Citation: Ep. Beck et al., IS OVX1 A SUITABLE MARKER FOR ENDOMETRIAL CANCER, Gynecologic oncology, 65(2), 1997, pp. 291-296
LYSOPHOSPHATIDYLCHOLINE STIMULATES ACTIVATOR PROTEIN-1 AND THE C-JUN N-TERMINAL KINASE-ACTIVITY
Authors: FANG XJ GIBSON S FLOWERS M FURUI T BAST RC MILLS GB
Citation: Xj. Fang et al., LYSOPHOSPHATIDYLCHOLINE STIMULATES ACTIVATOR PROTEIN-1 AND THE C-JUN N-TERMINAL KINASE-ACTIVITY, The Journal of biological chemistry, 272(21), 1997, pp. 13683-13689
RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO) ATTENUATES HIGH-DOSE CARBOPLATIN (C)-INDUCED THROMBOCYTOPENIA IN PATIENTS WITH GYNECOLOGIC MALIGNANCY
Authors: VADHANRAJ S VERSCHRAEGEN C MCGARRY L BUESORAMOS C KUDELKA A FREEDMAN R EDWARDS C BEVERS M LEVENBACK C GERSHENSON D JONES D YANG T BAST RC KAVANAGH J
Citation: S. Vadhanraj et al., RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO) ATTENUATES HIGH-DOSE CARBOPLATIN (C)-INDUCED THROMBOCYTOPENIA IN PATIENTS WITH GYNECOLOGIC MALIGNANCY, Blood, 90(10), 1997, pp. 2581-2581
TUMOR-MARKER UTILITY GRADING SYSTEM - A FRAMEWORK TO EVALUATE CLINICAL UTILITY OF TUMOR-MARKERS
Authors: HAYES DF BAST RC DESCH CE FRITSCHE H KEMENY NE JESSUP JM LOCKER GY MACDONALD JS MENNEL RG NORTON L RAVDIN P TAUBE S WINN RJ
Citation: Df. Hayes et al., TUMOR-MARKER UTILITY GRADING SYSTEM - A FRAMEWORK TO EVALUATE CLINICAL UTILITY OF TUMOR-MARKERS, Journal of the National Cancer Institute, 88(20), 1996, pp. 1456-1466
BREAST-CANCER CELLS ARE EFFECTIVELY PURGED FROM PERIPHERAL-BLOOD PROGENITOR CELLS WITH AN IMMUNOMAGNETIC TECHNIQUE
Authors: TYER CL VREDENBURGH JJ HEIMER M PETERS WP BAST RC
Citation: Cl. Tyer et al., BREAST-CANCER CELLS ARE EFFECTIVELY PURGED FROM PERIPHERAL-BLOOD PROGENITOR CELLS WITH AN IMMUNOMAGNETIC TECHNIQUE, Clinical cancer research, 2(1), 1996, pp. 81-86
ELEVATED SERUM LEVELS OF MACROPHAGE-COLONY-STIMULATING FACTOR AND OVX1, 11 MONTHS PRIOR TO THE DIAGNOSIS OF STAGE-IC OVARIAN-CANCER
Authors: WOOLAS R XU FJ JACOBS I ORAM D BAST RC
Citation: R. Woolas et al., ELEVATED SERUM LEVELS OF MACROPHAGE-COLONY-STIMULATING FACTOR AND OVX1, 11 MONTHS PRIOR TO THE DIAGNOSIS OF STAGE-IC OVARIAN-CANCER, International journal of gynecological cancer, 6(2), 1996, pp. 156-158
IMMUNOHISTOCHEMICAL CHARACTERIZATION OF 22 MONOCLONAL-ANTIBODIES AGAINST THE CA125 ANTIGEN - 2ND REPORT FROM THE ISOBM TD-1 WORKSHOP
Authors: NAP M VITALI A NUSTAD K BAST RC OBRIEN TJ NILSSON O SEGUIN P SURESH MR BORMER OP SAGA T DEBRUIJN HWA NOZAWA S KREUTZ FT JETTE D SAKAHARA H GADNELL M ENDO K BARLOW EH WARREN D PAUS E HAMMARSTROM S KENEMANS P HILGERS J
Citation: M. Nap et al., IMMUNOHISTOCHEMICAL CHARACTERIZATION OF 22 MONOCLONAL-ANTIBODIES AGAINST THE CA125 ANTIGEN - 2ND REPORT FROM THE ISOBM TD-1 WORKSHOP, Tumor biology, 17(6), 1996, pp. 325-331
SPECIFICITY AND AFFINITY OF 26 MONOCLONAL-ANTIBODIES AGAINST THE CA-125 ANTIGEN - FIRST REPORT FROM THE ISOBM TD-1 WORKSHOP
Authors: NUSTAD K BAST RC OBRIEN TJ NILSSON O SEGUIN P SURESH MR SAGA T NOZAWA S BORMER OP DEBRUIJN HWA NAP M VITALI A GADNELL M CLARK J SHIGEMASA K KARLSSON B KREUTZ FT JETTE D SAKAHARA H ENDO K PAUS E WARREN D HAMMARSTROM S KENEMANS P HILGERS J
Citation: K. Nustad et al., SPECIFICITY AND AFFINITY OF 26 MONOCLONAL-ANTIBODIES AGAINST THE CA-125 ANTIGEN - FIRST REPORT FROM THE ISOBM TD-1 WORKSHOP, Tumor biology, 17(4), 1996, pp. 196-219
HIGH-SENSITIVITY AND SPECIFICITY OF SCREENING FOR OVARIAN-CANCER WITHTHE RISK OF OVARIAN-CANCER (ROC) ALGORITHM-BASED ON RISING CA125 LEVELS
Authors: SKATES SJ JACOBS IJ SJOVALL K EINHORN N XU FJ YU YH BAST RC KNAPP RC
Citation: Sj. Skates et al., HIGH-SENSITIVITY AND SPECIFICITY OF SCREENING FOR OVARIAN-CANCER WITHTHE RISK OF OVARIAN-CANCER (ROC) ALGORITHM-BASED ON RISING CA125 LEVELS, Journal of clinical oncology, 14(5), 1996, pp. 2007-2007
CLINICAL-PRACTICE GUIDELINES FOR THE USE OF TUMOR-MARKERS IN BREAST AND COLORECTAL-CANCER
Authors: BAST RC BATES S BREDT AB DESCH CE FRITSCHE H FUES L HAYES DF KEMENY NE KRAGEN M JESSUP J LOCKER GY MACDONALD JS MENNEL RG NORTON L RAVDIN P SMITH TJ TAUBE S WINN RJ
Citation: Rc. Bast et al., CLINICAL-PRACTICE GUIDELINES FOR THE USE OF TUMOR-MARKERS IN BREAST AND COLORECTAL-CANCER, Journal of clinical oncology, 14(10), 1996, pp. 2843-2877
Risultati: 1-25 | 26-50 | 51-75 | 76-81